InvestorsHub Logo
Followers 9
Posts 1630
Boards Moderated 1
Alias Born 06/24/2020

Re: Bubae post# 9241

Tuesday, 03/22/2022 11:03:48 AM

Tuesday, March 22, 2022 11:03:48 AM

Post# of 11018
Thank you again for your reply and perspective regarding $MSTO. This forum provides the opportunity for both sides of the coin. Thus, we would still encourage those who have an interest to review many of the previous posts on the forum discussing various viewpoints and counterpoints as noted. In addition for us it is not that relative to compare other OTCs with 100B AS and beyond; yet we keep those tickers in our rear view mirror.

Further, we agree PRs can be problematic at times in the OTC with extreme 27A and 21E liberties as we have seen from CEO Josh. It is our expectation we will see the $12 in revenue a thing of the past within the coming 60 days and at the close of the current escrow funding. An issue then will be the amount encumbered during the build process.

In addition, with respect to the 30% that item has been thoroughly discussed as well and we would encourage those who have an interest to review many of the previous posts on the forum discussing various viewpoints and counterpoints as noted. As many of us learned in college one would want to come prepared for a healthy debate and as such, on this forum and in past posts many of the tools necessary for an informed response is readily available.

We hope the "bunch of talk" will help those who have waited patiently to reap the anticipated returns on their long term investment. Happy trading.